Evidence map›Paper›PMID 30707944›Full record

ArticleArchives of biochemistry and biophysics2019

The isolated C-terminal nuclear localization sequence of the breast cancer metastasis suppressor 1 is disordered.

David Pantoja-Uceda, José L Neira, Lellys M Contreras, Christa A Manton, Danny R Welch, Bruno Rizzuti

Abstract read
In one paragraph

Article in Archives of biochemistry and biophysics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 4 countries.

David Pantoja-UcedaInstituto de Química Física Rocasolano (IQFR), CSIC, 28006, Madrid, Spain.
José L NeiraInstituto de Biología Molecular y Celular, Universidad Miguel Hernández, 03202, Elche, Alicante, Spain; Instituto de Biocomputación y Física de Sistemas Complejos, Joint Units IQFR-CSIC-BIFI, and GBSC-CSIC-BIFI, Universidad de Zaragoza, 50009, Zaragoza, Spain. Electronic address: jlneira@umh.es.
Lellys M ContrerasCenter for Environmental Biology and Chemistry Research, Facultad Experimental de Ciencias y Tecnología, Universidad de Carabobo, 2001, Valencia, Venezuela.
Christa A MantonDepartment of Cancer Biology, The University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Danny R WelchDepartment of Cancer Biology, The University of Kansas Medical Center, Kansas City, KS, 66160, USA; The University of Kansas Cancer Center, Kansas City, KS, 66160, USA.
Bruno RizzutiCNR-NANOTEC, Licryl-UOS Cosenza and CEMIF.Cal, Department of Physics, University of Calabria, 87036, Rende, Italy. Electronic address: bruno.rizzuti@cnr.it.
The University of Kansas Cancer Center · USInstituto de Química Física Blas Cabrera · ESIstituto di Nanotecnologia · ITUniversitat de Miguel Hernández d'Elx · ESUniversity of Carabobo · VE

Funding

Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NICOLE L NOLLEN · 2012 to 2026
$40.1M
MOLECULAR REGULATION OF BREAST CANCER METASTASISR01CA087728 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WELCH, DANNY R. · 2000 to 2008
$2.7M
NCI NIH HHS P30 CA168524NCI NIH HHS R01 CA087728
6 · The paper itself

Abstract

BRMS1 is a 246-residue-long protein belonging to the family of metastasis suppressors. It is a predominantly nuclear protein, although it can also function in the cytoplasm. At its C terminus, it has a region that is predicted to be a nuclear localization sequence (NLS); this region, NLS2, is necessary for metastasis suppression. We have studied in vitro and in silico the conformational preferences in aqueous solution of a peptide (NLS2-pep) that comprises the NLS2 of BRMS1, to test whether it has a preferred conformation that could be responsible for its function. Our spectroscopic (far-UV circular dichroism, DOSY-NMR and 2D-NMR) and computational (all-atom molecular dynamics) results indicate that NLS2-pep was disordered in aqueous solution. Furthermore, it did not acquire a structure even when experiments were performed in a more hydrophobic environment, such as the one provided by 2,2,2-trifluoroethanol (TFE). The hydrodynamic radius of the peptide in water was identical to that of a random-coil sequence, in agreement with both our molecular simulations and other theoretical predictions. Thus, we suggest that NLS2 is a disordered region, with non pre-formed structure, that participates in metastasis suppression.

Indexed as

Nuclear Localization SignalsBreast NeoplasmsHumansHydrophobic and Hydrophilic InteractionsProtein ConformationRepressor ProteinsSpectrum AnalysisBRMS1 protein, humanNuclear Localization SignalsRepressor ProteinsCircular dichroismMolecular dynamicsNuclear localization sequenceNuclear magnetic resonance

Identifiers

PMID30707944
PMCPMC6532052
OpenAlexW2911708774

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.